ClinConnect ClinConnect Logo
Search / Trial NCT06813950

Impact of a Physical Activity Program on the Health-Related Quality of Life in Pediatric Cancer Patients

Launched by SOCIEDAD DE LUCHA CONTRA EL CÁNCER · Feb 3, 2025

Trial Information

Current as of August 21, 2025

Not yet recruiting

Keywords

Physical Activity Quality Of Life Physical Activity Programs Lifestyle

ClinConnect Summary

This clinical trial is studying how a structured physical activity program can improve the quality of life for children and teens with cancer in Quito, Ecuador. The research aims to find out if participating in a supervised exercise program over 10 weeks can help these young patients feel better physically and emotionally, especially since many children with cancer do not get enough exercise. The study will involve 90 participants aged 8 to 18 who are either currently receiving treatment for cancer or are in the post-treatment phase.

Eligible participants must live in Quito and be treated at specific hospitals. Throughout the trial, all participants will fill out surveys to measure their health-related quality of life at the start, after completing the program, and a few months later. The goal is to gather important information that could help include physical activity as part of cancer care for young patients in similar settings. If you're considering participation, this study could be a valuable opportunity to help improve the health and well-being of pediatric cancer patients.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Age range: Participants must be between 8 and 18 years old at the start of the study.
  • 2. Residency: Patients residing within the city limits of Quito, Ecuador. 3. Treatment status:
  • • Patients are being evaluated or treated at Hospitals SOLCA and Baca Ortiz.
  • Patients are either currently undergoing active treatment for pediatric malignancies, or
  • Patients are in the post-treatment phase after a pediatric cancer diagnosis.
  • The volunteer or a family member that lives with the possible participant has a cellphone so the survey can be administered and answered.
  • Exclusion Criteria:
  • 1. The presence of a malignant solid tumor which has not yet been surgically addressed.
  • 2. A psychiatric diagnosis of cognitive impairment. 3. A diagnosis of osteosarcoma. 4. A history of cardiac pathology. 5. The patient is in the pediatric inpatient ward or was one month prior to the enrollment phase.
  • 6. The patient is stationed at the pediatric intensive care unit. 7. The patient received high-dose chemotherapy with methotrexate greater than 1000 mg/m2/dose or cytarabine greater than 1 g/m2/dose in the last month.

About Sociedad De Lucha Contra El Cáncer

The Sociedad de Lucha Contra el Cáncer (SLCC) is a prominent non-profit organization dedicated to the fight against cancer through research, education, and patient support. As a clinical trial sponsor, SLCC actively funds and oversees innovative research initiatives aimed at advancing cancer treatment and improving patient outcomes. With a commitment to fostering collaboration among healthcare professionals, researchers, and patients, SLCC plays a vital role in the development of new therapeutic strategies and the dissemination of critical information to enhance awareness and prevention efforts. Through its comprehensive approach, SLCC strives to make significant contributions to the global battle against cancer.

Locations

Quito, , Ecuador

Quito, Pichincha, Ecuador

Patients applied

0 patients applied

Trial Officials

Gustavo Galárraga, MPH

Principal Investigator

Sociedad de Lucha Contra el Cáncer

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported